Pubblicazioni

New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis

2022 - CANCER TREATMENT REVIEWS

Lombardi, Pasquale; Filetti, Marco; Falcone, Rosa; Di Bidino, Rossella; Iacovelli, Roberto; Ciccarese, Chiara; Bria, Emilio; Tortora, Giampaolo; Scambia, Giovanni; Daniele, Gennaro

Stereotactic and hypofractionated radiotherapy associated with immune checkpoint inhibitor drugs: Analysis of local control, toxicity, and outcome in a single research centre case study

2021 - ANTICANCER RESEARCH

Anzellini, D.; de Sanctis, V.; Valeriani, M.; Reverberi, C.; Marinelli, L.; Massaro, M.; Vullo, G.; Facondo, G.; Sigillo, R. C.; Tosi, E.; Osti, M. F.

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity

2019 - JOURNAL FOR IMMUNOTHERAPY OF CANCER

Minniti, G.; Anzellini, D.; Reverberi, C.; Cappellini, G. C. A.; Marchetti, L.; Bianciardi, F.; Bozzao, A.; Osti, M.; Gentile, P. C.; Esposito, V.

Adjuvant ovarian suppression, high-dose chemotherapy and immunotherapy for premenopausal patients with high-risk breast cancer

2015 - ANTICANCER RESEARCH

Recchia, Francesco; Candeloro, Giampiero; Rosselli, Michele; Bratta, Massimo; Pasta, Vittorio; D'Orazi, Valerio; Fumagalli, Luca A; Rea, Silvio